Five Prime Therapeutics - Ownership and Business Overview

Life ScienceCompany

Five Prime Therapeutics Ownership

Who owns Five Prime Therapeutics?

Five Prime Therapeutics is owned by Amgen. It was acquired on March 4, 2021.

Was Five Prime Therapeutics formerly PE-backed?

Yes. Five Prime Therapeutics was formerly owned by 1 private investor.

Five Prime Therapeutics Business Overview

Where is Five Prime Therapeutics headquartered?

Five Prime Therapeutics is headquartered in South San Francisco, California.

What is Five Prime Therapeutics’ revenue?

Five Prime Therapeutics disclosed revenue of 15M USD for 2019 and 50M USD for 2018.

How many employees does Five Prime Therapeutics have?

Five Prime Therapeutics has 87 employees.

What sector is Five Prime Therapeutics in?

Five Prime Therapeutics is a life science company.

When was Five Prime Therapeutics founded?

Five Prime Therapeutics was founded in 2001.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.

Five Prime Therapeutics, Inc.

111 Oyster Point Boulevard,
South San Francisco, California 94080
United States,
(415) 365-5600
www.fiveprime.com

Five Prime Therapeutics, Inc. is a pre-clinical stage biotech company discovering innovative protein and antibody therapeutics. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. Five Prime Therapeutics was founded in 2001 and is based in South San Francisco, California.


 Subscribe to unlock this and 206,651
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.